The close contacts were defined as family members who shared the residence with the patient, social contacts who visited with patients when ill, and health care workers who provided medical services without effective personal protection during the period from one day before his illness onset to isolation in accordance with China's guidelines for prevention and control of human H7N9 virus infection.
1

Hemagglutination inhibition and microneutralization assays
Sera from close contacts were screened with a horse RBC, hemagglutination inhibition (HI) assay against H7N9 virus.
2 Briefly, sera were pre-treated with receptor destroying enzyme RDE (II) "Seiken" (Denka Seiken Co. Ltd., Tokyo, Japan) and 
Solid-phase binding assay
Receptor binding specificity was analyzed by a solid-phase direct binding assay biotinylated sialylglycopolymers: 39-sialyllactose-PAA-biotin (39SL-PAA, 39
Neu5Aca2-3Galb1-4Glc) and 69-sialyllactosamine-PAA-biotin (69SLN-PAA, 69
Neu5Aca2-6Galb1-4Glcb) (Cat. No. 01-038, 01-039, Glycotech, Gaithersburg, MD) as previously described. 4 Briefly, serial dilutions (0.039μg/ml, 0.08μg/ml, 0.16μg/ml, 0.3125μg/ml, 0.625μg/ml, 1.25μg/ml, 2.5μg/ml and 5μg/ml) of 3'-sialyllactose-PAA-biotin and 6'-sialyllactosamine-PAA-biotin were prepared in PBS; 100 ml of this dilution was added to each well of the 96-well microtiter plates 
